Atlas Trials

Study of Azacytidine Combined With Lenalidomide As Maintenance Therapy Based on MRD Monitoring in AML

Clinical trial NCT04490707 · UNKNOWN

Trial details

NCT number
NCT04490707
Sponsor
Ge Zheng
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Acute Myeloid Leukemia in Remission
Start date
2020-09-01
Primary completion
2022-12-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.